<<

– the silent

Dr. W.M. Coombs, INTRODUCTION possibility of excess exposure to hazardous chemi- Tel: 083 653 9859, Manganese was first discovered by Sheele in cals in South Africa. e-mail: mcoombs@ iafrica.com Sweden in 1774, and named ‘manganese’ by Guyton de Marveau in 1785. South Africa, with more EXPOSURE LEVELS Volker R. Schillack, than 50 million tons of alumino-silicates, contains Exposure levels differ worldwide; TLV – ACGIH: Analytical toxicologist, Ampath, around 40% of the world’s known reserves of these 0,2 mg/m3, OSHA 5,0 mg/m3 respectively from the Drs Du Buisson minerals and accounts for nearly half of the West- US and SA. SA has a level 25 times higher than the & Partners, P.O. Box 4419, ern world’s production. With manganese reserve in US. Arcadia, 0007. excess of 4000Mt, 80% of the world’s known man- Tel: 012 427 1738/ ganese ore deposits are located in the Northern ABSORPTION, DISTRIBUTION AND 012 427 1858 e-mail: schillackv@ Cape and North West Province. The country’s annual Manganese is an essential element for and ampath.co.za output in 1999 was 3122Kt, of which 1569Kt was is absorbed via and water intake. It is part of exported. the mitochondrial super oxide dismutase Couper first described industrial manganese (SOD) in and is essential for many animal in 1837 in five workers in France, who made species for the formation of bone and connective bleaching powders using manganese dioxide. He , as well as the of carbohydrates found that long-term exposure to manganese dust and lipids. The daily requirements for humans is caused a peculiar extra-pyramidal syndrome. How- about 2–3 mg (WHO 1981). ever, his observations were forgotten for a long time, Manganese in the workplace is mainly absorbed and it was only in 1919 that a definite relationship through inhalation. After inhalation (or parenteral and between the epidemiologic, clinical, and pathological oral exposure) the absorbed manganese is rapidly effects that manganese poisoning has on the central eliminated from the blood and distributed mainly to was established by Edsall, Wilbur and the . Manganese preferentially accumulates in Drinker in the USA. With the onset of World War II the tissue rich in mitochondria. It also penetrates the accelerated growth of the steel industry led to a high blood-brain barrier. The biological half- for man- incidence of manganese poisoning, crippling as many ganese is between 36 and 41 days, but for manga- as 25% of their working population, as reported by nese in the brain it is considerably longer. Manga- Schualer et al (1957), who described in great detail nese in the blood binds to the erythrocyte porphyrin the extra-pyramidal syndrome. complex. Excretion of manganese is mostly through Important uses for manganese include the pro- the faeces, thus the bile route is the main route of duction of steel, non-ferrous alloys, dry batter- excretion for manganese. Only 0,1 – 1,3% of the daily ies, electrode coating in welding rods, glass indus- intake of manganese is excreted through the . try, textile bleaching and in fertilizers. It is also used in the chemical industry. Considerable exposure SYMPTOMS AND SIGNS takes place from manganese-containing ores, The symptoms and signs of manganese poisoning especially ores. Organic manganese has been or can occur after variable periods of used as a fungicide and is still used as an anti-knock- heavy exposure ranging from 6 months to 3 years at ing agent in gasoline. Most hazardous manganese average air levels of 5 mg/m3. The disease begins exposure occurs in the mining and the smelting of insidiously with headache, irritability and occasion- ore. ally psychotic behaviour. The latter, manganese In this decade, manganese poisoning has become psychosis, occurs most frequently in miners rather rare, even in developing countries. The recent cases than in industrial workers, and consists of transitory of manganese poisoning in South Africa remind us psychological disturbances such as hallucinations, of the need to keep a high index of suspicion to the compulsive behaviour and emotional instability.

10 MAY/JUNE 2005 OCCUPATIONAL HEALTH SOUTHERN AFRICA Severe somnolence, followed by insomnia, is often 4. Main manifestations are psychiatric and neuro- found early in the disease. As manganese exposure logical. continues, symptoms include generalized muscle Neither blood nor urinary manganese levels weakness, speech impairment, inco-ordination and correlate with symptom and signs or the neurological impotence; tremors, paresthesia and muscle cramps and psychiatric manifestations. Therefore blood and have been noted. In advanced stages the subject ex- urinary concentration are of little value in the diagno- hibits excessive salivation, inappropriate emotional sis of manganese poisoning other than confirming reaction and Parkinson-like symptoms, such as mask- exposure or assisting in differential diagnosis. like faces, severe muscle rigidity and gait disorders. The dystonic posture of the limb is often accompa- BIOLOGICAL EFFECT MONITORING nied by painful cramps, and is characteristic of findings The systems affected can be monitored with in manganese poisoning. Manganism is reversible if chest X-rays, functions, liver functions, full blood it is limited to psychological disturbances and the counts, specialized neurological and psychiatric worker is removed from exposure early. questionnaires and medical examinations that elicit Exposure levels associated with advanced specific symptoms and signs. manganism typically have to be very high. 150 cases were found in three mines where air dust levels BIOLOGICAL MONITORING reached 450 mg/m3. Recent studies revealed seven Normal concentrations of manganese in blood range cases with defined signs and symptoms out of 117 from 7–12 µg/l (Chang, W.). Analysis of manganese workers exposed to 5 mg/m3. levels in biological samples for exposure is a very An association between manganese exposure important component in determining individual and and pulmonary effects including pneumonia, chronic group trends of exposure in the work environment. bronchitis and airway impairment has been observed. Due to the short biological half-life in blood of less Extrapolation from animal studies suggests that it is than 5 minutes, blood concentration will only be unlikely that manganese could be the sole etiologic elevated very shortly after manganese exposure. agent responsible for serious pathological changes The homeostatic mechanisms involved in trying to in the . Instead it is possible that susceptibility keep tissue concentrations on a constant level make to is increased. it more difficult to detect increased blood levels. Blood Acute poisoning by manganese is rare, but may manganese is mainly a reflection of body burden of occur following large ingested or inhaled amounts of the . Because of the very low percentage ex- manganese. cretion in urine, this medium is also not a good Metal-fume fever, an influenza-like illness is indicator of exposure but if high may assist in prov- characterized by chills, fever, sweating, nausea and ing exposure. On a group basis, manganese in urine, coughing. The syndrome begins 4–12 hours after to some extent, seems to reflect recent exposure exposure to manganese oxide fumes and lasts 24 and will be higher than the non-exposed group. The hours without causing permanent damage. main importance of biological monitoring is to de- termine trends to prevent increasing levels of DIAGNOSIS manganese. Normal concentrations of manganese There is no specific diagnostic test for manganese in urine range from 1–8 µg/l (Chang, W.). poisoning, and the diagnosis depends chiefly upon a combination of characteristic neurological features SOUTH AFRICAN MANGANESE MONITORING and an occupational history of exposure (Cook et RESULTS al., 1974). Figures 1 and 2 reflect the exposure to manganese Diagnosis has been based on the following points: for South Africa during the period 2003 – 2005 from 1. Symptoms and signs appear after exposure to dust bio-monitoring results. Significant increases in urine or fumes of manganese for more than 3 months. levels (above 40 µg/l), is noticeable over the period 2. Symptoms and signs appear gradually and then 2004 and 2005. Blood manganese levels are show- become progressive, to some extent. ing some improvement in 2005, however, the sample 3. The initial symptoms are various and vague. They size is small. No relationship between the airborne are asthenia, anorexia, apathy, insomnia and manganese concentration and the biological daytime-drowsiness, and a slowing down in perform- indicator of exposure could be established. Reliable ing motor acts. air levels were available when compiling this report.

OCCUPATIONAL HEALTH SOUTHERN AFRICA MAY/JUNE 2005 11 CONCLUSION exposure levels should be reviewed as a matter of Even though there is little if any correlation between urgency. A review of manganese medical surveil- the level of manganese as measured by urinary and lance protocols for early detection and removal from blood samples, biomonitoring may be of value in exposure should be established and standardised assessment of exposure or in differential diagnosis. through tripartite consultations. Body burden and exposure monitoring may assist in prevention or early disease diagnosis but in uncertain exposure scenarios as in developing countries or high REFERENCES exposure legislative levels as in South Africa it can be a 1. Lars, Freiberg, Gunnar, F., Nordberg, V., Vouk. B. Handbook on the of metal. Second edition. Amsterdam – New good proxy for prioritisation and prevention measures. York – Oxford. Elsevier Science Publishers, 1990. There is a clear need to establish non exposed 2. Lauwerys, Robert R., Perine, Hoet. Industrial chemical exposure. New York and London. CRC Press, 2001. population manganese levels as well as research 3. NIOSH – Manganese and compounds. Medical Surveillance 2002. on the correlation between exposure and blood and 4. Chang, Louis W. Toxicology of . New York and London. urine levels in SA working populations. Legislated CRC Press, 1996.

Range µg/l

FIGURE 1. URINE MANGANESE LEVELS.

Range µg/l

FIGURE 2. BLOOD MANGANESE LEVELS.

These pages are sponsored by Drs Du Buisson & Partners, Pretoria

12 MAY/JUNE 2005 OCCUPATIONAL HEALTH SOUTHERN AFRICA